Skip to Content
Series

Pfizer CEO Albert Bourla reflects on unprecedented vaccine development

February 02, 2021 00:00 AM UTC
- Updated March 09, 2021 19:21 PM UTC

Fortune Editor-in-Chief Clifton Leaf talks with Bourla about the remarkable development process.